查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2067487

人工智慧市場規模、佔有率和趨勢分析報告（臨床決策支援）：按組件、應用、部署模式、最終用途、地區和細分市場分類（2026-2033 年）

Artificial Intelligence In Clinical Decision Support Market Size, Share & Trends Analysis Report By Component, Application, By Deployment Mode, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

臨床決策支援領域人工智慧市場概述

2025 年全球臨床決策支援 (CDS) 人工智慧市場規模預計為 13 億美元，預計到 2033 年將達到 45 億美元，2026 年至 2033 年的複合年成長率為 17.1%。

電子健康記錄(EHR) 的日益普及、向基於價值的醫療保健模式的轉變以及對簡化臨床工作流程日益成長的需求，正在推動市場成長。

以下各節概述了人工智慧在臨床決策支援產業發展的關鍵促進因素，重點關注電子健康記錄(EHR) 的日益普及、向基於價值的醫療模式的加速轉變以及對簡化臨床工作流程日益成長的需求。

市場促進因素和趨勢

電子健康記錄(EHR) 的普及應用

電子健康記錄(EHR) 的日益普及對於人工智慧在臨床決策支援中的應用至關重要，因為這些平台依賴大量的數位化患者數據來產生可操作的洞察。在美國、歐洲和亞太部分地區的醫療保健系統中，EHR 的普及率很高，這得益於監管要求和獎勵計劃的支持。這種廣泛的數位化使得人工智慧臨床決策支援系統 (AI-CDSS) 解決方案能夠存取按時間順序排列的患者記錄，包括病歷、檢驗結果、影像資料和用藥記錄。將 CDSS 無縫整合到 EHR 工作流程中，可實現即時臨床建議，從而提高診斷準確性和治療決策的有效性。例如，Oracle 的 EHR 整合 CDSS 原型利用 Oracle 雲端基礎架構 (OCI) 的 AI Vision 來分析患者影像並準確檢測皮膚癌。

加速以以金額為準的醫療模式轉型

向以以金額為準的醫療模式轉變，將報銷與患者療效、臨床品質和成本控制掛鉤，正在改變醫療服務的提供方式。人工智慧臨床決策支援系統（AI-CDSS）增強了護理協調和持續的患者管理。透過分析即時和歷史患者數據，這些系統能夠識別高風險患者、預測再入院風險並支持及時干預。與電子健康記錄（EHR）和人群健康管理平台的整合，使醫療服務提供者能夠追蹤治療結果、確保遵循臨床指南並最佳化資源利用。這有助於促進預防性護理，尤其是在慢性病管理中，持續監測和及時回應至關重要。例如，2026年3月發表在《英國醫學雜誌》（BMJ）上的一項研究分析了在中國40家醫院實施的人工智慧臨床決策支援系統，其中21,603名急性缺血性腦中風患者被隨機分配到人工智慧輔助治療組或標準治療組。人工智慧臨床決策支援系統評估了人口統計、影像學、實驗室結果和生命徵象等數據，以產生針對患者的最佳化指南建議。這項研究表明，中風臨床決策支援系統 (CDSS) 可減少 3 個月內的新發血管事件，提高中風護理質量，並降低血管事件的長期發生率。

簡化臨床工作流程的需求日益成長

醫療系統患者數量不斷增加、人員短缺以及日益沉重的行政負擔，正推動著對精簡臨床工作流程的需求日益成長。臨床醫生花費大量時間在文件記錄、資料搜尋和護理協調上，這限制了他們與患者的直接互動，並導致職業倦怠。人工智慧在臨床決策支援中的應用，透過自動化日常任務並將決策支援功能整合到現有臨床工作流程中，有效應對了這些挑戰。人工智慧臨床決策支援系統（AI-CDSS）還能透過標準化工作流程和減少護理服務差異，提升跨領域協作和營運效率。這些系統透過提供統一的患者數據和可操作的洞察，加速了部門間的溝通。預測分析能夠改善排班、資源分配和病患分診，最大限度地減少延誤，並最佳化臨床資源的利用。例如，2026年4月，Abridge與Wolters Kluwer旗下的UpToDate合作，在其環境文件平台中擴展了人工智慧驅動的臨床決策支援（CDS）功能。臨床醫生可以在諮詢期間（包括諮詢前、諮詢期間和諮詢後）透過與患者的對話和記錄獲取基於證據的即時建議。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：人工智慧在臨床決策支援領域的市場：變數、趨勢和範圍

  • 市場譜系展望
  • 市場動態
  • 用於臨床決策支援的人工智慧市場分析工具

第4章：人工智慧在臨床決策支援領域的市場：按組件分類的估算與趨勢分析

  • 全球臨床決策支援人工智慧市場：基於組件的波動分析
  • 從 2021 年到 2033 年，按組成部分細分，對全球人工智慧市場在臨床決策支援領域的規模和趨勢進行分析。
  • 軟體
  • 服務

第5章：人工智慧在臨床決策支援領域的市場：基於應用的估算和趨勢分析

  • 全球臨床決策支援人工智慧市場：基於應用的波動分析
  • 2021年至2033年全球人工智慧市場規模及臨床決策支援應用趨勢
  • 診斷決策支持
  • 治療決策支持
  • 藥物管理
  • 預測分析和風險評估
  • 最佳化臨床工作流程
  • 其他

第6章：人工智慧在臨床決策支援領域的市場：按部署方式分類的估算與趨勢分析

  • 全球臨床決策支援人工智慧市場：按部署方式分類的波動分析
  • 從 2021 年到 2033 年，按實施類型分類的全球人工智慧市場規模和臨床決策支援趨勢分析。
  • 網路和雲端
  • 現場

第7章：人工智慧在臨床決策支援領域的市場：按最終用途分類的估算和趨勢分析

  • 全球臨床決策支援人工智慧市場：按最終用途分類的波動分析
  • 2021年至2033年全球人工智慧市場規模及臨床決策支援最終用途趨勢
  • 醫院
  • 私人執業者及門診診所
  • 製藥和生物技術公司
  • 付款人
  • 其他

第8章：人工智慧在臨床決策支援領域的市場：區域估算與趨勢分析

  • 2025年及2033年區域市佔率分析
  • 區域市場概覽
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭情勢

  • 公司和競爭對手的分類
  • 策略規劃
  • 2025年公司市場分析
  • 公司簡介列表
    • UpToDate, Inc.（Wolters Kluwer）
    • Siemens Healthcare Private Limited
    • GE Healthcare
    • Royal Philips NV
    • Premier Inc.
    • Natus
    • PERSYST DEVELOPMENT LLC
    • Oracle
    • Aidoc
    • Viz.ai
    • Merative
    • Etiometry
Product Code: GVR-4-68040-908-9

Artificial Intelligence In Clinical Decision Support Market Summary

The global artificial intelligence in clinical decision support market size was estimated at USD 1.3 billion in 2025 and is projected to reach USD 4.5 billion in 2033, growing at a CAGR of 17.1% from 2026 to 2033. The increasing adoption of Electronic Health Records (EHRs), the shift toward value-based care models, and the growing demand for clinical workflow efficiency are driving market growth.

The section below outlines the key factors driving the growth of the artificial intelligence (AI) in clinical decision support industry, highlighting the increasing adoption of Electronic Health Records (EHRs), the increasing shift toward value-based care models, and the growing demand for clinical workflow efficiency.

Market Drivers and Dynamics

Increasing Adoption of Electronic Health Records (EHRs)

The increasing adoption of Electronic Health Records (EHRs) is essential for AI in Clinical Decision Support, as these platforms rely on large volumes of digitized patient data to generate actionable insights. Healthcare systems across the U.S., Europe, and parts of the Asia Pacific have achieved high levels of EHR penetration, supported by regulatory mandates and incentive programs. This widespread digitization allows AI-CDSS solutions to access longitudinal patient records, including medical history, lab results, imaging data, and medication profiles. Seamless integration of CDSS within EHR workflows enables real-time clinical recommendations at the point of care, improving diagnostic accuracy and treatment decisions. For instance, Oracle's EHR-integrated CDSS prototype uses Oracle Cloud Infrastructure (OCI) AI Vision to analyze patient images for precise skin cancer detection.

Increasing Shift toward Value-Based Care Models

The shift toward value-based care models is transforming healthcare delivery by linking reimbursement to patient outcomes, clinical quality, and cost control. AI-CDSS strengthens care coordination and ongoing patient management. By analyzing real-time and historical patient data, these systems pinpoint high-risk individuals, predict readmission risk, and support timely interventions. Integration with EHRs and population health platforms enables providers to track outcomes, ensure adherence to clinical guidelines, and streamline resource use. This facilitates proactive care, especially in chronic disease management, where continuous monitoring and timely changes are vital. For example, a BMJ study in March 2026 analyzed an AI-powered clinical decision support system across 40 Chinese hospitals, randomizing 21,603 patients with acute ischemic stroke to AI-assisted or standard care. AI CDSS assessed data, including demographics, imaging, labs, and vitals, to generate tailored guideline recommendations. The study showed that the stroke CDSS reduced new vascular events at three months, improved stroke care quality, and lowered long-term vascular event rates.

Growing Demand for Clinical Workflow Efficiency

Rising patient volumes, workforce shortages, and increasing administrative burdens across healthcare systems are driving the growing demand for clinical workflow efficiency. Clinicians spend a significant portion of their time on documentation, data retrieval, and care coordination, which limits direct patient interaction and contributes to burnout. AI in Clinical Decision Support addresses these challenges by automating routine tasks and embedding decision support within existing clinical workflows. AI-CDSS also enhances interdisciplinary coordination and operational efficiency by standardizing workflows and reducing variability in care delivery. These systems facilitate faster communication between departments by providing unified access to patient data and actionable insights. Predictive analytics capabilities enable better scheduling, resource allocation, and patient triage, minimizing delays and optimizing utilization of clinical assets. For instance, in April 2026, Abridge partnered with Wolters Kluwer's UpToDate to expand AI clinical decision support (CDS) within its ambient documentation platform. Clinicians access real-time, evidence-based recommendations from patient conversations and notes during visits, including pre-, intra-, and post-encounter.

Global Artificial Intelligence In Clinical Decision Support Market Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global artificial intelligence (AI) in clinical decision support market report based on component, application, deployment mode, end use, and region:

  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Software
  • Services
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Diagnostic Decision Support
  • Therapeutic Decision Support
  • Medication Management
  • Clinical Workflow Optimization
  • Predictive Analytics & Risk Assessment
  • Others
  • Deployment Mode Outlook (Revenue, USD Million, 2021 - 2033)
  • Web & Cloud-based
  • On-premise
  • End use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Physician Practices & Ambulatory Clinics
  • Pharmaceutical & Biotech Companies
  • Payer
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Component Segment
    • 1.2.2. Application Segment
    • 1.2.3. Deployment Mode Segment
    • 1.2.4. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Artificial Intelligence (AI) in Clinical Decision Support Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. AI-Driven Therapeutic Decision Support Systems (CDS) Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal Landscape
      • 3.3.2.6. Social Landscape

Chapter 4. Artificial Intelligence (AI) in Clinical Decision Support Market: Component Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global AI-Driven Therapeutic Decision Support Systems (CDS) Market Component Movement Analysis
  • 4.3. Global AI-Driven Therapeutic Decision Support Systems (CDS) Market Size & Trend Analysis, by Component, 2021 to 2033 (USD Million)
  • 4.4. Software
    • 4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5. Services
    • 4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Artificial Intelligence (AI) in Clinical Decision Support Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global AI-Driven Therapeutic Decision Support Systems (CDS) Market Application Movement Analysis
  • 5.3. Global AI-Driven Therapeutic Decision Support Systems (CDS) Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Diagnostic Decision Support
    • 5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.5. Therapeutic Decision Support
    • 5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.6. Medication Management
    • 5.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.7. Predictive Analytics & Risk Assessment
    • 5.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.8. Clinical Workflow Optimization
    • 5.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.9. Others
    • 5.9.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Artificial Intelligence (AI) in Clinical Decision Support Market: Deployment Mode Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global AI-Driven Therapeutic Decision Support Systems (CDS) Market: Deployment Mode Movement Analysis
  • 6.3. Global AI-Driven Therapeutic Decision Support Systems (CDS) Market Size & Trend Analysis, by Medical Condition, 2021 to 2033 (USD Million)
  • 6.4. Web & Cloud-based
    • 6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5. On-Premise
    • 6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Artificial Intelligence (AI) in Clinical Decision Support Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global AI-Driven Therapeutic Decision Support Systems (CDS) Market: End Use Movement Analysis
  • 7.3. Global AI-Driven Therapeutic Decision Support Systems (CDS) Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Hospitals
    • 7.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.5. Physician Practices & Ambulatory Clinics
    • 7.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.6. Pharmaceutical & Biotechnology Companies
    • 7.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.7. Payers
    • 7.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.8. Others
    • 7.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. Artificial Intelligence (AI) in Clinical Decision Support Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2025 & 2033
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033
  • 8.4. North America
    • 8.4.1. U.S.
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.4.2. Canada
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.4.3. Mexico
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.5. Europe
    • 8.5.1. UK
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.2. Germany
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.3. France
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.4. Italy
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.5. Spain
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.6. Norway
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.7. Sweden
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Regulatory framework
      • 8.5.8.3. Competitive scenario
      • 8.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Japan
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.6.2. China
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.6.3. India
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.6.4. Australia
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.6.6. Thailand
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Brazil
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.7.2. Argentina
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.8. MEA
    • 8.8.1. South Africa
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.8.2. Saudi Arabia
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.8.3. UAE
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory framework
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.8.4. Kuwait
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Regulatory framework
      • 8.8.4.3. Competitive scenario
      • 8.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2025
  • 9.4. Company Profiles/Listing
    • 9.4.1. UpToDate, Inc. (Wolters Kluwer)
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Siemens Healthcare Private Limited
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. GE Healthcare
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Royal Philips NV
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Premier Inc.
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Natus
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. PERSYST DEVELOPMENT LLC
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Oracle
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Aidoc
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Viz.ai
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. Merative
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Product benchmarking
      • 9.4.11.4. Strategic initiatives
    • 9.4.12. Etiometry
      • 9.4.12.1. Company overview
      • 9.4.12.2. Financial performance
      • 9.4.12.3. Product benchmarking
      • 9.4.12.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America AI in clinical decision support market, by region, 2021 - 2033 (USD Million)
  • Table 4 North America AI in clinical decision support market, by component, 2021 - 2033 (USD Million)
  • Table 5 North America AI in clinical decision support market, by application, 2021 - 2033 (USD Million)
  • Table 6 North America AI in clinical decision support market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 7 North America AI in clinical decision support market, by end use, 2021 - 2033 (USD Million)
  • Table 8 U.S. AI in clinical decision support market, by component, 2021 - 2033 (USD Million)
  • Table 9 U.S. AI in clinical decision support market, by application, 2021 - 2033 (USD Million)
  • Table 10 U.S. AI in clinical decision support market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 11 U.S. AI in clinical decision support market, by end use, 2021 - 2033 (USD Million)
  • Table 12 Canada AI in clinical decision support market, by component, 2021 - 2033 (USD Million)
  • Table 13 Canada AI in clinical decision support market, by application, 2021 - 2033 (USD Million)
  • Table 14 Canada AI in clinical decision support market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 15 Canada AI in clinical decision support market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Mexico AI in clinical decision support market, by component, 2021 - 2033 (USD Million)
  • Table 17 Mexico AI in clinical decision support market, by application, 2021 - 2033 (USD Million)
  • Table 18 Mexico AI in clinical decision support market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 19 Mexico AI in clinical decision support market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Europe AI in clinical decision support market, by region, 2021 - 2033 (USD Million)
  • Table 21 Europe AI in clinical decision support market, by component, 2021 - 2033 (USD Million)
  • Table 22 Europe AI in clinical decision support market, by application, 2021 - 2033 (USD Million)
  • Table 23 Europe AI in clinical decision support market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 24 Europe AI in clinical decision support market, by end use, 2021 - 2033 (USD Million)
  • Table 25 Germany AI in clinical decision support market, by component, 2021 - 2033 (USD Million)
  • Table 26 Germany AI in clinical decision support market, by application, 2021 - 2033 (USD Million)
  • Table 27 Germany AI in clinical decision support market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 28 Germany AI in clinical decision support market, by end use, 2021 - 2033 (USD Million)
  • Table 29 France AI in clinical decision support market, by component, 2021 - 2033 (USD Million)
  • Table 30 France AI in clinical decision support market, by application, 2021 - 2033 (USD Million)
  • Table 31 France AI in clinical decision support market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 32 France AI in clinical decision support market, by end use, 2021 - 2033 (USD Million)
  • Table 33 UK AI in clinical decision support market, by component, 2021 - 2033 (USD Million)
  • Table 34 UK AI in clinical decision support market, by application, 2021 - 2033 (USD Million)
  • Table 35 UK AI in clinical decision support market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 36 UK AI in clinical decision support market, by end use, 2021 - 2033 (USD Million)
  • Table 37 Italy AI in clinical decision support market, by component, 2021 - 2033 (USD Million)
  • Table 38 Italy AI in clinical decision support market, by application, 2021 - 2033 (USD Million)
  • Table 39 Italy AI in clinical decision support market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 40 Italy AI in clinical decision support market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Spain AI in clinical decision support market, by component, 2021 - 2033 (USD Million)
  • Table 42 Spain AI in clinical decision support market, by application, 2021 - 2033 (USD Million)
  • Table 43 Spain AI in clinical decision support market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 44 Spain AI in clinical decision support market, by end use, 2021 - 2033 (USD Million)
  • Table 45 Denmark AI in clinical decision support market, by component, 2021 - 2033 (USD Million)
  • Table 46 Denmark AI in clinical decision support market, by application, 2021 - 2033 (USD Million)
  • Table 47 Denmark AI in clinical decision support market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 48 Denmark AI in clinical decision support market, by end use, 2021 - 2033 (USD Million)
  • Table 49 Sweden AI in clinical decision support market, by component, 2021 - 2033 (USD Million)
  • Table 50 Sweden AI in clinical decision support market, by application, 2021 - 2033 (USD Million)
  • Table 51 Sweden AI in clinical decision support market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 52 Sweden AI in clinical decision support market, by end use, 2021 - 2033 (USD Million)
  • Table 53 Norway AI in clinical decision support market, by component, 2021 - 2033 (USD Million)
  • Table 54 Norway AI in clinical decision support market, by application, 2021 - 2033 (USD Million)
  • Table 55 Norway AI in clinical decision support market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 56 Norway AI in clinical decision support market, by end use, 2021 - 2033 (USD Million)
  • Table 57 Asia Pacific AI in clinical decision support market, by region, 2021 - 2033 (USD Million)
  • Table 58 Asia Pacific AI in clinical decision support market, by component, 2021 - 2033 (USD Million)
  • Table 59 Asia Pacific AI in clinical decision support market, by application, 2021 - 2033 (USD Million)
  • Table 60 Asia Pacific AI in clinical decision support market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific AI in clinical decision support market, by end use, 2021 - 2033 (USD Million)
  • Table 62 China AI in clinical decision support market, by component, 2021 - 2033 (USD Million)
  • Table 63 China AI in clinical decision support market, by application, 2021 - 2033 (USD Million)
  • Table 64 China AI in clinical decision support market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 65 China AI in clinical decision support market, by end use, 2021 - 2033 (USD Million)
  • Table 66 Japan AI in clinical decision support market, by component, 2021 - 2033 (USD Million)
  • Table 67 Japan AI in clinical decision support market, by application, 2021 - 2033 (USD Million)
  • Table 68 Japan AI in clinical decision support market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 69 Japan AI in clinical decision support market, by end use, 2021 - 2033 (USD Million)
  • Table 70 India AI in clinical decision support market, by component, 2021 - 2033 (USD Million)
  • Table 71 India AI in clinical decision support market, by application, 2021 - 2033 (USD Million)
  • Table 72 India AI in clinical decision support market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 73 India AI in clinical decision support market, by end use, 2021 - 2033 (USD Million)
  • Table 74 South Korea AI in clinical decision support market, by component, 2021 - 2033 (USD Million)
  • Table 75 South Korea AI in clinical decision support market, by application, 2021 - 2033 (USD Million)
  • Table 76 South Korea AI in clinical decision support market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 77 South Korea AI in clinical decision support market, by end use, 2021 - 2033 (USD Million)
  • Table 78 Australia AI in clinical decision support market, by component, 2021 - 2033 (USD Million)
  • Table 79 Australia AI in clinical decision support market, by application, 2021 - 2033 (USD Million)
  • Table 80 Australia AI in clinical decision support market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 81 Australia AI in clinical decision support market, by end use, 2021 - 2033 (USD Million)
  • Table 82 Thailand AI in clinical decision support market, by component, 2021 - 2033 (USD Million)
  • Table 83 Thailand AI in clinical decision support market, by application, 2021 - 2033 (USD Million)
  • Table 84 Thailand AI in clinical decision support market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 85 Thailand AI in clinical decision support market, by end use, 2021 - 2033 (USD Million)
  • Table 86 Latin America AI in clinical decision support market, by region, 2021 - 2033 (USD Million)
  • Table 87 Latin America AI in clinical decision support market, by component, 2021 - 2033 (USD Million)
  • Table 88 Latin America AI in clinical decision support market, by application, 2021 - 2033 (USD Million)
  • Table 89 Latin America AI in clinical decision support market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 90 Latin America AI in clinical decision support market, by end use, 2021 - 2033 (USD Million)
  • Table 91 Brazil AI in clinical decision support market, by component, 2021 - 2033 (USD Million)
  • Table 92 Brazil AI in clinical decision support market, by application, 2021 - 2033 (USD Million)
  • Table 93 Brazil AI in clinical decision support market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 94 Brazil AI in clinical decision support market, by end use, 2021 - 2033 (USD Million)
  • Table 95 Argentina AI in clinical decision support market, by region, 2021 - 2033 (USD Million)
  • Table 96 Argentina AI in clinical decision support market, by component, 2021 - 2033 (USD Million)
  • Table 97 Argentina AI in clinical decision support market, by application, 2021 - 2033 (USD Million)
  • Table 98 Argentina AI in clinical decision support market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 99 Argentina AI in clinical decision support market, by end use, 2021 - 2033 (USD Million)
  • Table 100 MEA AI in clinical decision support market, by region, 2021 - 2033 (USD Million)
  • Table 101 MEA AI in clinical decision support market, by component, 2021 - 2033 (USD Million)
  • Table 102 MEA AI in clinical decision support market, by application, 2021 - 2033 (USD Million)
  • Table 103 MEA AI in clinical decision support market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 104 MEA AI in clinical decision support market, by end use, 2021 - 2033 (USD Million)
  • Table 105 South Africa AI in clinical decision support market, by component, 2021 - 2033 (USD Million)
  • Table 106 South Africa AI in clinical decision support market, by application, 2021 - 2033 (USD Million)
  • Table 107 South Africa AI in clinical decision support market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 108 South Africa AI in clinical decision support market, by end use, 2021 - 2033 (USD Million)
  • Table 109 Saudi Arabia AI in clinical decision support market, by component, 2021 - 2033 (USD Million)
  • Table 110 Saudi Arabia AI in clinical decision support market, by application, 2021 - 2033 (USD Million)
  • Table 111 Saudi Arabia AI in clinical decision support market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 112 Saudi Arabia AI in clinical decision support market, by end use, 2021 - 2033 (USD Million)
  • Table 113 UAE AI in clinical decision support market, by component, 2021 - 2033 (USD Million)
  • Table 114 UAE AI in clinical decision support market, by application, 2021 - 2033 (USD Million)
  • Table 115 UAE AI in clinical decision support market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 116 UAE AI in clinical decision support market, by end use, 2021 - 2033 (USD Million)
  • Table 117 Kuwait AI in clinical decision support market, by component, 2021 - 2033 (USD Million)
  • Table 118 Kuwait AI in clinical decision support market, by application, 2021 - 2033 (USD Million)
  • Table 119 Kuwait AI in clinical decision support market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 120 Kuwait AI in clinical decision support market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 AI in clinical decision support market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Commodity flow analysis
  • Fig. 5 Parent market analysis
  • Fig. 6 AI in clinical decision support market snapshot
  • Fig. 7 AI in clinical decision support market segment snapshot (part 1)
  • Fig. 8 AI in clinical decision support market segment snapshot (part 2)
  • Fig. 9 AI in clinical decision support market competitive landscape snapshot
  • Fig. 10 Market research process
  • Fig. 11 Parent market outlook (USD Billion) (2025)
  • Fig. 12 AI in clinical decision support market dynamics
  • Fig. 13 AI in clinical decision support market: Porter's five forces analysis
  • Fig. 14 AI in clinical decision support market: PESTLE analysis
  • Fig. 15 AI in clinical decision support market, component outlook key takeaways (USD million)
  • Fig. 16 AI in clinical decision support market: component movement analysis, 2025 & 2033 (USD Million)
  • Fig. 17 Software and GPT platform market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 AI in clinical decision support market, application outlook key takeaways (USD Million)
  • Fig. 20 AI in clinical decision support market: Application movement analysis, 2025 & 2033 (USD Million)
  • Fig. 21 Clinical decision support market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Clinical documentation & ambient AI market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Drug discovery & life sciences market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Patient engagement & virtual assistants market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Administrative & revenue cycle management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 AI in clinical decision support market, deployment mode outlook key takeaways (USD Million)
  • Fig. 28 AI in clinical decision support market: Deployment mode movement analysis, 2025 & 2033 (USD Million)
  • Fig. 29 Web & cloud-based market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 On-premise market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 AI in clinical decision support market, end use outlook key takeaways (USD Million)
  • Fig. 32 AI in clinical decision support market: End use analysis, 2025 & 2033 (USD Million)
  • Fig. 33 Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Physician practices & ambulatory clinics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Payers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Regional marketplace: Key takeaways
  • Fig. 39 Clinical Decision Support Systems (CDS) Market: Regional outlook
  • Fig. 40 North America AI in clinical decision support market, 2021 - 2033 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 US AI in clinical decision support market, 2021 - 2033 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Canada AI in clinical decision support market, 2021 - 2033 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Mexico AI in clinical decision support market, 2021 - 2033 (USD Million)
  • Fig. 47 Europe AI in clinical decision support market, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 UK AI in clinical decision support market, 2021 - 2033 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Germany AI in clinical decision support market, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 France AI in clinical decision support market, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Italy AI in clinical decision support market, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Spain AI in clinical decision support market, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Sweden AI in clinical decision support market, 2021 - 2033 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Denmark AI in clinical decision support market, 2021 - 2033 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Norway AI in clinical decision support market, 2021 - 2033 (USD Million)
  • Fig. 64 Asia Pacific AI in clinical decision support market, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Japan AI in clinical decision support market, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 China AI in clinical decision support market, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 India AI in clinical decision support market, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Australia AI in clinical decision support market, 2021 - 2033 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Thailand AI in clinical decision support market, 2021 - 2033 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 South Korea AI in clinical decision support market, 2021 - 2033 (USD Million)
  • Fig. 77 Latin America AI in clinical decision support market, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Brazil AI in clinical decision support market, 2021 - 2033 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Argentina AI in clinical decision support market, 2021 - 2033 (USD Million)
  • Fig. 82 MEA AI in clinical decision support market, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 South Africa AI in clinical decision support market, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Saudi Arabia AI in clinical decision support market, 2021 - 2033 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 UAE AI in clinical decision support market, 2021 - 2033 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Kuwait AI in clinical decision support market, 2021 - 2033 (USD Million)
  • Fig. 91 Company categorization
  • Fig. 92 Company market position analysis, 2025
  • Fig. 93 Strategic Framework